Bristol-Myers Squibb Company
IMIDAZOPYRIDAZINE COMPOUNDS
Last updated:
Abstract:
Compounds of formula (I) or a stereoisomer or pharmaceutically-acceptable salt thereof, are useful in the modulation of IL-12, IL-23 and/or IFN.alpha., by acting on Tyk-2 to cause signal transduction inhibition. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
16 Nov 2017
Issue date:
21 Oct 2021